検索結果 - Timothy Kilchenmann

Automatic speaker diarization for natural conversation analysis in autism clinical trials 著者: James O’Sullivan, Guy Bogaarts, Philipp Schoenenberger, Julian Tillmann, David Slater, Nima Mesgarani, Eckhart Eule, Timothy Kilchenmann, Lorraine Murtagh, Joerg Hipp, Michael Lindemann, Florian Lipsmeier, Wei-Yi Cheng, David Nobbs, Christopher Chatham

全文の入手

Evolving regulatory perspectives on digital health technologies for medicinal product development 著者: Seya Colloud, Thomas Metcalfe, Scott Askin, Shibeshih Belachew, Johannes Ammann, Ernst Bos, Timothy Kilchenmann, Paul Strijbos, Damien Eggenspieler, Laurent Servais, Chloé Garay, Athanasios Konstantakopoulos, Armin Ritzhaupt, Thorsten Vetter, Claudia Vincenzi, Francesca Cerreta

全文の入手

Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease 著者: Florian Lipsmeier, Kirsten I. Taylor, Ronald B. Postuma, Ekaterina Volkova-Volkmar, Timothy Kilchenmann, Brit Mollenhauer, Atieh Bamdadian, Werner L. Popp, Wei-Yi Cheng, Yan-Ping Zhang, Detlef Wolf, Jens Schjodt-Eriksen, Anne Boulay, Hanno Svoboda, Wagner Zago, Gennaro Pagano, Michael Lindemann

全文の入手

Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab 著者: Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht, Judith Anzures-Cabrera, David Summers, Markus Abt, Annabelle Monnet, Timothy Kilchenmann, Jens Schjodt-Eriksen, Laurent Essioux, Thomas Kustermann, Wagner Zago, Hanno Svoboda, Tania Nikolcheva, Ronald B. Postuma, Gennaro Pagano, Michael Lindemann, PASADENA Investigators, Prasinezumab Study Group

全文の入手